Menu
ÚHKT

RNDr. Hana Votavová , Ph.D.

odborný pracovník v laboratorních metodách

Tel: +420 221 977 306
Email: Hana.Votavova@uhkt.cz

Pracoviště:

Impaktované publikace

[21]

Kracmarova, A.; Cermak, J.; Brdicka, R.; Bruchova, H.

High expression of ERCC1, FLT1, NME4 and PCNA associated with poor prognosis and advanced stages in myelodysplastic syndrome

[rok vydání 2008, impact factor 1.939]

[22]

Dostalova Merkerova, M.; Hrustincova, A.; Krejcik, Z.; Votavova, H.; Ratajova, E.; Cermak, J.; Belickova, M.

Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes

[rok vydání 2017, impact factor 1.696 ]

[23]

Belickova, M.; Cermak, J.; Dostalova Merkerova, M.; Vesela, J.; Krejcik, Z.; Cechova, E.; Zemanova, Z.; Michalova, K.; Votavova, H.; Caniga, M.; Neuwirtova, R.; Jonasova, A.

Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q)

[rok vydání 2012, impact factor 1.667 ]

[24]

Belickova, M.; Dostalova Merkerova, M.; Votavova, H.; Valka, J.; Vesela, J.; Pejsova, B.; Hajkova, H.; Klema, J.; Cermak, J.; Jonasova, A.

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms

[rok vydání 2016, impact factor 1.610 ]

[25]

Merkerova, M.; Bruchova, H.; Kracmarova, A.; Klamova, H.; Brdicka, R.

Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation

[rok vydání 2007, impact factor 1.512]

[26]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Urbanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Genetic variant screening of DNA repair genes in myelodysplastic syndrome identifies a novel mutation in the XRCC2 gene

[rok vydání 2019, impact factor 1.483 ]

[27]

Bruchova, H.; Borovanova, T.; Klamova, H.; Brdicka, R.

Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea

[rok vydání 2006, impact factor 1.335]

[28]

Merkerova, M.; Bruchova, H.; Brdicka, R.

JNK2 and p38 MAPK over-expressions do not represent key events in chronic myeloid leukemia transformation

[rok vydání 2008, impact factor 1.208]

[29]

Vasikova, A.; Budinska, E.; Belickova, M.; Cermak, J.; Bruchova, H.

Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome

[rok vydání 2009, impact factor 1.192]

[30]

Hruštincová, A.; Votavová, H.; Dostálová Merkerová, M.

Circulating microRNAs: methodological aspects in detection of these biomarkers

[rok vydání 2016, impact factor 0.833]

[31]

Merkerova, M.; Klamova, H.; Brdicka, R.; Bruchova, H.

Targeting of gene expression by siRNA in CML primary cells

[rok vydání 2007, impact factor 0.829]

[32]

Beličková, M.; Bruchová, H.; Cajthamlová, H.; Hrkal, Z.; Brdička, R.

Genes involved in the destruction of leukaemic cells by induced photosensitivity

[rok vydání 2006, impact factor 0.351]